Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality

BACKGROUND: Conflicting findings and the analysis of unpublished and retracted data have led to controversy on the safety of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in people with COVID-19 infection. This meta-analysis examined the association of prescription of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernando, Malindu E., Drovandi, Aaron, Golledge, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421238/
https://www.ncbi.nlm.nih.gov/pubmed/34488897
http://dx.doi.org/10.1186/s13643-021-01802-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421238/
https://www.ncbi.nlm.nih.gov/pubmed/34488897
http://dx.doi.org/10.1186/s13643-021-01802-6

Ejemplares similares